3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
3
Oropharyngeal Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Pheochromocytoma
2
Paraganglioma
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Mouth Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Hodgkin Disease
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Stage III Lung Non-Small Cell Cancer AJCC v7
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Interventions
Specimen Handling
5
Nivolumab
4
Magnetic Resonance Spectroscopy
4
cabozantinib
3
Gemcitabine
3
enfortumab vedotin
2
Ipilimumab
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
trastuzumab deruxtecan
1
relatlimab
1
pembrolizumab
1
eribulin
1
erdafitinib
1
avelumab
1
atezolizumab
1
Lenalidomide
1
Doxorubicin
1
Contrast Media
1
Cisplatin
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
Fluorodeoxyglucose F18
×
90 days
×
Clear all
No trials found.